Turing Pharma Ex-CEO Shkreli Faces More Charges

May 4, 2016

Martin Shkreli, making headlines for hiking up the price of a life-saving cancer/AIDS drug by 5,000 percent, will soon face new charges, says an article in CNN Money.

Shkreli appeared in U.S. District Court in Brooklyn on May 3 on existing fraud charges where it was announced that he'll face an additional indictment. He's been accused of illegally siphoning money from one of his companies to another to pay off bad market bets, the story said.

A new court hearing has been scheduled for June 6. Read the full article